Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Immediate, Pre-emptive Fibrinogen Concentrate in Patients With Trauma Haemorrhage Needing Haemostatic Resuscitation
NCT02344069Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2015
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic hemorrhage comparing Fibrinogen with Placebo (2 arms). Primary endpoint: Thrombelastograph Functional Fibrinogen maximum amplitude. Started Feb 2015; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT02344069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344069.